An Open-label Study of the Safety and Efficacy of Tag-7 Gene-modified Tumor Cell-based Vaccine in Patients With Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer

Conditions:   Melanoma;   Kidney Cancer Intervention:   Biological: Tag-7 gene modified inactivated tumor cells Sponsors:   N.N. Petrov National Medical Research Center of Oncology;   Institute of Gene Biology Russian Academy of Sciences Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials